Accepting new patients
Fritz C. Eilber, MD
- Surgical Oncology
Surgical Oncology
|
200 Medical Plaza,
Suite B265,
Los Angeles, CA
90095
About
Preferred Name: Fritz C. Eilber
Frederick (Fritz) C. Eilber is a Professor of Surgery, Division of Surgical Oncology with a dual appointment in the Department of Molecular and Medical Pharmacology. He is Director of the UCLA Sarcoma Clinical/Translational Research Program within the Jonsson Comprehensive Cancer Center and the UCLA Sarcoma Program.
Business Office
10833 Le Conte Ave
Room 54-140 CHS
Los Angeles, CA 90095-1782
Languages
Education
Medical Board Certification
Surgery, American Board of Surgery, 2003
Fellowship
Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 2004
Residency
General Surgery, UCLA School of Medicine, 2002
Internship
General Surgery, UCLA School of Medicine, 1996
Degree
MD, UCLA School of Medicine, 1995
Recognitions
- Super Doctors® Southern California, 2022, 2023
- 2008 Shelby Richter Research Award - Sarcoma Foundation America
- 2008 Society of Nuclear Medicine Siemens Award (Senior Author)
- See More
Locations
Hospital Affiliations
Ronald Reagan UCLA Medical Center
UCLA Santa Monica Medical Center
Medical Services
Areas of Focus
Videos
Lumps and Bumps Along the Way
Leiomyosarcoma: Personalized Sarcoma Therapy
Research
Interests
My research is focused on translating molecular oncology from the laboratory to the clinic in a rapid and clinically relevant manner with the goal of swiftly impacting patient care. Our long-term objective is to rationally apply molecularly targeted therapies in the context of defined genetic lesions thus developing effective and individualized therapeutic strategies for patients with sarcoma and other solid tumors. We have recently focused on applying molecular imaging to evaluate response to systemic therapy (traditional chemotherapy, targeted therapy) and direct regional therapies (surgery, radiation therapy, embolization) in solid tumors.
Publications
In the News
- Loss of Tumor Suppressor Gene Essential to Transforming Benign Nerve Tumors into Cancers
- Imaging: FDG-PET/CT: early predictor of treatment response in soft-tissue sarcoma
- Study finds PET superior to standard tools for evaluating cancer treatment
- PET study garners widespread media attention
- Using PET/CT Imaging, Researchers Can Tell in a Single Treatment if Chemotherapy is Working
- Father and son: Fighting sarcoma with different tools
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- L.A. Care
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of health care plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.
Recognitions
- Super Doctors® Southern California, 2022, 2023
- 2008 Shelby Richter Research Award - Sarcoma Foundation America
- 2008 Society of Nuclear Medicine Siemens Award (Senior Author)
- 2008 Society of Nuclear Medicine Travel Award (Senior Author)
- 2008 ASCO Foundation Merit Award (Abst ID:10510, Senior Author)
- 2008 ASCO Foundation Merit Award (Abst ID:10528, Senior Author)
- 2007 Jonsson Cancer Center Award for Clinical Excellence, UCLA
- 2007 ASCO Foundation Merit Award (Senior Author)
- 2004 Chairman's Clinical Research Award, MSKCC Dept of Surgery
- 2004 ASCO Foundation Merit Award
- 2002 Outstanding Student Teaching Award, UCLA Dept of Surgery
- 1996 Outstanding 1st Year Resident, UCLA Dept of Surgery